BRPI0407052A - Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização - Google Patents

Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização

Info

Publication number
BRPI0407052A
BRPI0407052A BR0407052-6A BRPI0407052A BRPI0407052A BR PI0407052 A BRPI0407052 A BR PI0407052A BR PI0407052 A BRPI0407052 A BR PI0407052A BR PI0407052 A BRPI0407052 A BR PI0407052A
Authority
BR
Brazil
Prior art keywords
alkenyl
alkyl
alkynyl
independently selected
halogen
Prior art date
Application number
BR0407052-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Atsuo Kuki
Xinqiang Li
Michael Bruno Plewe
Hai Wang
Junhu Zhang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0407052A publication Critical patent/BRPI0407052A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR0407052-6A 2003-01-27 2004-01-23 Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização BRPI0407052A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44322303P 2003-01-27 2003-01-27
PCT/IB2004/000259 WO2004067531A1 (en) 2003-01-27 2004-01-23 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use

Publications (1)

Publication Number Publication Date
BRPI0407052A true BRPI0407052A (pt) 2006-01-17

Family

ID=32825309

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0407052-6A BRPI0407052A (pt) 2003-01-27 2004-01-23 Inibidores da hiv-integrase, composições farmacêuticas, e métodos para sua utilização

Country Status (7)

Country Link
US (2) US7001912B2 (cg-RX-API-DMAC7.html)
EP (1) EP1590349A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006516606A (cg-RX-API-DMAC7.html)
BR (1) BRPI0407052A (cg-RX-API-DMAC7.html)
CA (1) CA2513141A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05007563A (cg-RX-API-DMAC7.html)
WO (1) WO2004067531A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
CA2513141A1 (en) 2003-01-27 2004-08-12 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
CN100503607C (zh) * 2003-06-02 2009-06-24 新疆华世丹药物研究有限责任公司 去氢骆驼蓬碱衍生物类化合物及其应用
BRPI0510319A (pt) 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
DE602005002746T2 (de) * 2004-04-26 2008-02-07 Pfizer Inc. Inhibitoren des hiv-integrase-enzyms
EP1873155A1 (en) * 2004-04-26 2008-01-02 Pfizer Inc. Inhibitors of the HIV integrase enzyme
ES2529038T3 (es) * 2004-05-07 2015-02-16 Merck Sharp & Dohme Corp. Inhibidores de la integrasa de VIH
BRPI0616657A2 (pt) * 2005-10-07 2011-06-28 Pfizer Prod Inc inibidores da enzima hiv integrase
US20070219243A1 (en) * 2005-12-30 2007-09-20 Kearney Brian P Method for improving the pharmacokinetics of HIV integrase inhibitors
CA2667826C (en) * 2006-10-28 2013-10-08 Methylgene Inc. Inhibitors of histone deacetylase
US20100256379A1 (en) * 2007-10-26 2010-10-07 Kagoshima University Anti-viral agent containing heterocyclic aromatic compound as active ingredient
US9151055B2 (en) 2009-02-25 2015-10-06 Owens Corning Intellectual Capital, Llc Hip and ridge roofing material
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN109369510A (zh) * 2018-10-31 2019-02-22 云南大学 具有抗hiv活性的双甲氧基取代咔唑类化合物制备及用途
EP4185564A1 (en) * 2020-07-23 2023-05-31 Merck Patent GmbH Tricyclic heterocycles
CN119431371B (zh) * 2024-10-22 2026-05-19 沈阳药科大学 一种β-卡波林3,6,9-位修饰衍生物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
GB8720125D0 (en) * 1987-08-26 1987-09-30 Roussel Lab Ltd Chemical compounds
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
EP1086101B1 (en) * 1998-06-12 2002-12-18 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Beta-carboline compounds
EP1209158A1 (en) * 2000-11-18 2002-05-29 Aventis Pharma Deutschland GmbH Substituted beta-carbolines
CN1659143A (zh) 2001-03-01 2005-08-24 盐野义制药株式会社 具有hiv整合酶抑制活性的含氮杂芳基化合物
JP4176477B2 (ja) 2001-03-01 2008-11-05 塩野義製薬株式会社 Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環誘導体
JP2003171381A (ja) 2001-09-25 2003-06-20 Takeda Chem Ind Ltd エントリー阻害剤
JP2003119137A (ja) 2001-10-10 2003-04-23 Japan Tobacco Inc Hiv阻害剤
EP1438310B1 (en) * 2001-10-19 2006-12-20 TransTech Pharma Inc. Beta-carbolin derivatives as ptp-inhibitors
CA2463975A1 (en) 2001-10-26 2003-05-01 Maria Emilia Di Francesco Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
AU2002349675A1 (en) 2001-12-05 2003-06-17 Shionogi And Co., Ltd. Derivative having hiv integrase inhibitory activity
CA2469592C (en) 2001-12-12 2005-08-23 Bristol-Myers Squibb Company Hiv integrase inhibitors
EP1467970B1 (en) 2002-01-17 2007-08-22 Merck & Co., Inc. Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
WO2003077857A2 (en) 2002-03-15 2003-09-25 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
CA2513141A1 (en) 2003-01-27 2004-08-12 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use

Also Published As

Publication number Publication date
US7001912B2 (en) 2006-02-21
EP1590349A1 (en) 2005-11-02
US20050165040A1 (en) 2005-07-28
JP2006516606A (ja) 2006-07-06
WO2004067531A1 (en) 2004-08-12
US20060122211A1 (en) 2006-06-08
MXPA05007563A (es) 2005-09-21
CA2513141A1 (en) 2004-08-12
US7138408B2 (en) 2006-11-21

Similar Documents

Publication Publication Date Title
ES2564352T3 (es) Derivados de tranilcipromina como inhibidores de la histona-desmetilasa LSD1 y/o LSD2
BR0308081A (pt) Inibidores de histona desacetilase
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
RU2342367C2 (ru) Ненуклеозидные ингибиторы i обратной транскриптазы, предназначенные для лечения заболеваний, опосредованных вич
BR0312999A (pt) Compostos, composições farmacêticas, método para aumentar a cognição, de tratamento, de inibição da atividade de enzima pde4 em um paciente
BR0010520A (pt) Novos compostos farmaceuticamente ativos
BR0307409A (pt) Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
BR0014137A (pt) Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica
BR112014009102A2 (pt) compostos químicos
MA37891B1 (fr) Alcoxypyrazoles comme activateurs de guanylate cyclase soluble
MA30911B1 (fr) Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine
HUP0402310A2 (hu) 1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
BRPI0418074B8 (pt) derivado de amida, composição farmacêutica, inibidor da tirosina cinase bcr-abl e agentes terapêuticos
BRPI0413533A (pt) derivados de malonamida que bloqueiam a atividade de gama-secretase
MA49956B1 (fr) Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak
MA31142B1 (fr) Derives heteroaryles de pyrrolidinyl et piperdinyl cetones.
NO20071117L (no) Substituerte propenyl-piperazinderivater som nye inhibitorer av histondeacetylase
MA30311B1 (fr) Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
ECSP088293A (es) Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado
ZA202304541B (en) Cdk inhibitors and their use as pharmaceuticals
MA49127B1 (fr) Dérivés d'indole n-substitués
SE0300120D0 (sv) Novel compounds
HRP20041087B1 (hr) Derivati n-acilaminobenzena kao selektivni inhibitori monoamin oksidaze b
ATE401080T1 (de) (3-((chinazolin-4-yl)amino)-1h-pyrazol-1- yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs
MXPA05007563A (es) Inhibidores de la integrasa del vih, composiciones farmaceuticas y metodos para su uso.

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.